home / stock / amam / amam quote
Last: | $10.13 |
---|---|
Change Percent: | 0.28% |
Open: | $10.53 |
Close: | $10.13 |
High: | $10.53 |
Low: | $9.59 |
Volume: | 1,305,379 |
Last Trade Date Time: | 03/16/2023 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$10.13 | $10.53 | $10.13 | $10.53 | $9.59 | 1,305,379 | 03-16-2023 |
$10.56 | $10.3 | $10.56 | $11.06 | $10.2121 | 1,352,261 | 03-15-2023 |
$10.55 | $10 | $10.55 | $10.66 | $9 | 1,735,406 | 03-14-2023 |
$10.25 | $9.26 | $10.25 | $11.18 | $9.26 | 3,064,889 | 03-13-2023 |
$9.69 | $8.92 | $9.69 | $9.9599 | $8.34 | 2,056,433 | 03-10-2023 |
$8.87 | $9.74 | $8.87 | $10.1 | $8.79 | 2,175,617 | 03-09-2023 |
$9.95 | $9.02 | $9.95 | $10.33 | $8.5 | 9,844,639 | 03-08-2023 |
$9.28 | $11.13 | $9.28 | $11.3 | $9.02 | 11,528,229 | 03-07-2023 |
$12.54 | $6.43 | $12.54 | $13.07 | $6.345 | 50,121,630 | 03-06-2023 |
$6.43 | $6.74 | $6.43 | $7.45 | $6.31 | 6,295,894 | 03-03-2023 |
$6.8 | $5.8 | $6.8 | $7.14 | $5.56 | 4,508,228 | 03-02-2023 |
$5.89 | $6.37 | $5.89 | $6.89 | $5.73 | 3,269,530 | 03-01-2023 |
$6.43 | $5.65 | $6.43 | $6.48 | $5.55 | 2,712,541 | 02-28-2023 |
$5.59 | $4.82 | $5.59 | $5.6799 | $4.69 | 3,451,159 | 02-27-2023 |
$5.03 | $5.47 | $5.03 | $5.85 | $4.73 | 5,746,003 | 02-24-2023 |
$6.53 | $4.56 | $6.53 | $7.39 | $4.4501 | 36,887,979 | 02-23-2023 |
$4.56 | $4.15 | $4.56 | $4.62 | $3.64 | 4,734,757 | 02-22-2023 |
$4.55 | $3.31 | $4.55 | $5.45 | $3.31 | 53,684,741 | 02-21-2023 |
$3.25 | $2.38 | $3.25 | $3.28 | $2.25 | 8,109,489 | 02-20-2023 |
$3.25 | $2.38 | $3.25 | $3.28 | $2.25 | 8,109,489 | 02-17-2023 |
News, Short Squeeze, Breakout and More Instantly...
Ambrx Biopharma Inc. American Depositary Shares (each representing seven) Company Name:
AMAM Stock Symbol:
NYSE Market:
Shandong Weigao Group Medical Polymer Co. Ltd. - Class H (SHWGF) is expected to report for Q4 2023 Country Garden Holdings Co., Ltd. ADR (CTRYY) is expected to report for Q4 2023 Mondi Plc ADR (New) (MONDY) is expected to report for Q4 2023 Telecom Italia S.p.A. ADR - Preference Share...
Ambrx Biopharma Inc. (AMAM) is expected to report $-0.41 for Q4 2023
SAN DIEGO, March 06, 2024 (GLOBE NEWSWIRE) -- Ambrx Biopharma, Inc., ("Ambrx" or the "Company") (NASDAQ:AMAM), today announced that its sharehol...